3D Tissue Models

4SC discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various autoimmune and cancer indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's balanced pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with leading pharmaceutical companies. 4SC AG is listed on the Frankfurt Stock Exchange (Prime Standard: VSC/ISIN DE0005753818), Germany.

Accomplishment Points: 40
2 members

Ranking Total Score # People # Speakers # Events # Presentations # Sponsorships
2824 9 2 1 3 3 0

Name Specialty Accomplish Score Popularity Score City, State Most Recent Event
Kohlhof, Hella No specialty recorded 39 Unavailable Epigenetic Enzymes in Drug Discovery Conference
Stefan , Henning No specialty recorded 1 Unavailable Planegg/Martinsried  
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.